- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.14 Å
- Oligo State
- homo-octamer
- Ligands
- 24 x HXJ: 2-[[(E,2S,3R)-2-(hexanoylamino)-3-oxidanyl-dec-4-enoxy]-oxidanyl-phosphoryl]oxyethyl-trimethyl-azanium(Non-covalent)
- 38 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 4 residues within 4Å:- Chain A: R.120, V.121, Y.122, K.123
Ligand excluded by PLIPSO4.4: 5 residues within 4Å:- Chain A: R.53, Q.130, Y.133, Y.138
- Ligands: HXJ.1
Ligand excluded by PLIPSO4.5: 5 residues within 4Å:- Chain A: W.149, R.161, E.173, H.175
- Chain B: H.63
Ligand excluded by PLIPSO4.6: 5 residues within 4Å:- Chain A: G.42, K.43, T.44, S.95
- Ligands: HTO.9
Ligand excluded by PLIPSO4.7: 2 residues within 4Å:- Chain A: R.79
- Chain H: H.169
Ligand excluded by PLIPSO4.8: 3 residues within 4Å:- Chain A: Y.51, F.52, R.53
Ligand excluded by PLIPSO4.13: 4 residues within 4Å:- Chain B: R.120, V.121, Y.122, K.123
Ligand excluded by PLIPSO4.14: 5 residues within 4Å:- Chain B: R.53, Q.130, Y.133, Y.138
- Ligands: HXJ.11
Ligand excluded by PLIPSO4.15: 4 residues within 4Å:- Chain B: R.161, E.173, H.175
- Chain C: H.63
Ligand excluded by PLIPSO4.16: 5 residues within 4Å:- Chain B: Y.113, S.114, W.116, R.144
- Ligands: HXJ.12
Ligand excluded by PLIPSO4.17: 4 residues within 4Å:- Chain B: W.149, H.150, S.151
- Chain C: R.127
Ligand excluded by PLIPSO4.22: 5 residues within 4Å:- Chain C: R.120, V.121, Y.122, K.123, Y.156
Ligand excluded by PLIPSO4.23: 5 residues within 4Å:- Chain C: R.53, Q.130, Y.133, Y.138
- Ligands: HXJ.19
Ligand excluded by PLIPSO4.24: 5 residues within 4Å:- Chain C: R.161, E.173, H.175
- Chain D: H.63, K.64
Ligand excluded by PLIPSO4.25: 4 residues within 4Å:- Chain C: S.114, W.116, R.144
- Ligands: HXJ.20
Ligand excluded by PLIPSO4.29: 4 residues within 4Å:- Chain D: R.120, V.121, Y.122, K.123
Ligand excluded by PLIPSO4.30: 5 residues within 4Å:- Chain D: R.53, Q.130, Y.133, Y.138
- Ligands: HXJ.26
Ligand excluded by PLIPSO4.31: 4 residues within 4Å:- Chain D: R.161, E.173, H.175
- Chain E: H.63
Ligand excluded by PLIPSO4.32: 5 residues within 4Å:- Chain D: W.112, S.114, W.116, R.144
- Ligands: HXJ.27
Ligand excluded by PLIPSO4.35: 4 residues within 4Å:- Chain E: R.120, V.121, Y.122, K.123
Ligand excluded by PLIPSO4.36: 5 residues within 4Å:- Chain E: R.53, Q.130, Y.133, Y.138
- Ligands: HXJ.33
Ligand excluded by PLIPSO4.37: 5 residues within 4Å:- Chain E: W.149, R.161, E.173, H.175
- Chain F: H.63
Ligand excluded by PLIPSO4.38: 5 residues within 4Å:- Chain E: G.42, K.43, T.44, S.95
- Ligands: HTO.41
Ligand excluded by PLIPSO4.39: 2 residues within 4Å:- Chain D: H.169
- Chain E: R.79
Ligand excluded by PLIPSO4.40: 3 residues within 4Å:- Chain E: Y.51, F.52, R.53
Ligand excluded by PLIPSO4.45: 4 residues within 4Å:- Chain F: R.120, V.121, Y.122, K.123
Ligand excluded by PLIPSO4.46: 5 residues within 4Å:- Chain F: R.53, Q.130, Y.133, Y.138
- Ligands: HXJ.43
Ligand excluded by PLIPSO4.47: 4 residues within 4Å:- Chain F: R.161, E.173, H.175
- Chain G: H.63
Ligand excluded by PLIPSO4.48: 5 residues within 4Å:- Chain F: Y.113, S.114, W.116, R.144
- Ligands: HXJ.44
Ligand excluded by PLIPSO4.49: 4 residues within 4Å:- Chain F: W.149, H.150, S.151
- Chain G: R.127
Ligand excluded by PLIPSO4.54: 5 residues within 4Å:- Chain G: R.120, V.121, Y.122, K.123, Y.156
Ligand excluded by PLIPSO4.55: 5 residues within 4Å:- Chain G: R.53, Q.130, Y.133, Y.138
- Ligands: HXJ.51
Ligand excluded by PLIPSO4.56: 5 residues within 4Å:- Chain G: R.161, E.173, H.175
- Chain H: H.63, K.64
Ligand excluded by PLIPSO4.57: 4 residues within 4Å:- Chain G: S.114, W.116, R.144
- Ligands: HXJ.52
Ligand excluded by PLIPSO4.61: 4 residues within 4Å:- Chain H: R.120, V.121, Y.122, K.123
Ligand excluded by PLIPSO4.62: 5 residues within 4Å:- Chain H: R.53, Q.130, Y.133, Y.138
- Ligands: HXJ.58
Ligand excluded by PLIPSO4.63: 4 residues within 4Å:- Chain A: H.63
- Chain H: R.161, E.173, H.175
Ligand excluded by PLIPSO4.64: 5 residues within 4Å:- Chain H: W.112, S.114, W.116, R.144
- Ligands: HXJ.59
Ligand excluded by PLIP- 2 x HTO: HEPTANE-1,2,3-TRIOL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tanaka, K. et al., Structural basis for self-assembly of a cytolytic pore lined by protein and lipid. Nat Commun (2015)
- Release Date
- 2015-03-04
- Peptides
- Fragaceatoxin C: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
AF
BG
CH
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.14 Å
- Oligo State
- homo-octamer
- Ligands
- 24 x HXJ: 2-[[(E,2S,3R)-2-(hexanoylamino)-3-oxidanyl-dec-4-enoxy]-oxidanyl-phosphoryl]oxyethyl-trimethyl-azanium(Non-covalent)
- 38 x SO4: SULFATE ION(Non-functional Binders)
- 2 x HTO: HEPTANE-1,2,3-TRIOL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tanaka, K. et al., Structural basis for self-assembly of a cytolytic pore lined by protein and lipid. Nat Commun (2015)
- Release Date
- 2015-03-04
- Peptides
- Fragaceatoxin C: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
AF
BG
CH
D - Membrane
-
We predict this structure to be a membrane protein.